Overall, these results indicate that PRDX6 prevents NNMT ubiquitination at lysine 23 and 210, leading to the inhibition of proteasomal degradation and upregulation of NNMT in ovarian cancer cells. Here, PRDX6 is linked to ovarian carcinoma.